Medical and Pharmaceutical Galvanize Therapeutics finds signs Aliya PEF may activate immune response in lung cancer The findings could help researchers understand whether Aliya treatments can complement existing cancer immunotherapies Joseph Morton4 days ago
Medical and Pharmaceutical Young Muay Thai fighter’s lung cancer death raises screening eligibility concerns Many heavy smokers live into their senior years while others are taken far too young Rowan Dunne6 days ago
Medical and Pharmaceutical Research shines light on efficacy of ‘Inflammacheck’ lung cancer breath test Small study yielded high accuracy, though larger-scale validation is still needed Rowan DunneAugust 19, 2026
Medical and Pharmaceutical New USD$60 blood test detects lung cancer using DNA chemical fingerprints The team extracts cell-free DNA from a blood sample and chemically processes selected sections Joseph MortonAugust 18, 2026
Medical and Pharmaceutical USC researchers use quantum AI to improve cancer imaging Doctors regularly use magnetic resonance imaging, computed tomography and ultrasound scans to diagnose diseases and plan treatments Joseph MortonAugust 14, 2026
Medical and Pharmaceutical Freenome gets FDA breakthrough designation for ‘SimpleScreen’ lung cancer blood test Achievement builds on firm securing agency's approval for a colorectal cancer test variation Rowan DunneAugust 13, 2026
Medical and Pharmaceutical Manitoba Lung Association and BioMark use blood biopsy to tackle radon threat They are organising a feasibility study assessing the efficacy of BioMark's blood test on those exposed to the gas Rowan DunneAugust 9, 2026
Medical and Pharmaceutical Lung cancer screening awareness remains low despite advances in early detection The 2026 Lung Health Barometer found only 33 per cent of adults knew low-dose CT screening is available for high-risk people Joseph MortonAugust 6, 2026
Medical and Pharmaceutical Stand Up To Cancer charity funds non-invasive lung cancer screening projects It will provide up to US$200K for each of the three initiatives Rowan DunneJuly 29, 2026
AI and Autonomy Tempus AI buys Personalis to strengthen AI-driven cancer monitoring platform The acquisition targets a cancer monitoring market that the companies estimate could reach USD$20 billion Joseph MortonJuly 29, 2026